TR201908151T4 - İzoindolin türevleri. - Google Patents

İzoindolin türevleri. Download PDF

Info

Publication number
TR201908151T4
TR201908151T4 TR2019/08151T TR201908151T TR201908151T4 TR 201908151 T4 TR201908151 T4 TR 201908151T4 TR 2019/08151 T TR2019/08151 T TR 2019/08151T TR 201908151 T TR201908151 T TR 201908151T TR 201908151 T4 TR201908151 T4 TR 201908151T4
Authority
TR
Turkey
Prior art keywords
relates
present
derivatives
isoindoline derivatives
isoindoline
Prior art date
Application number
TR2019/08151T
Other languages
English (en)
Inventor
Skolc David
Ates Ali̇
Jnoff Eric
Valade Anne
Mathieu Benoît
Sands Zara
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of TR201908151T4 publication Critical patent/TR201908151T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, izoindolin türevlerine ve bunların terapide kullanımına ilişkindir. Özellikle bu buluş, farmakolojik olarak aktif sübstitüe edilmiş izoindolin türevlerine ilişkindir. Daha özel haliyle, bu buluş, sübstitüe edilmiş 1,3-dihidroizoindolin-2(1H)-il türevlerine ilişkindir. Bu buluşa göre bileşikler, D1 Pozitif Allosterik Modülatörlerdir ve uygun olarak D1 reseptörlerinin bir rol oynadığı hastalıkların tedavisi için farmasötik maddeler olarak yararlıdır.
TR2019/08151T 2014-10-08 2015-10-06 İzoindolin türevleri. TR201908151T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14188150 2014-10-08

Publications (1)

Publication Number Publication Date
TR201908151T4 true TR201908151T4 (tr) 2019-06-21

Family

ID=51790568

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/08151T TR201908151T4 (tr) 2014-10-08 2015-10-06 İzoindolin türevleri.

Country Status (5)

Country Link
US (1) US9975873B2 (tr)
EP (1) EP3204374B1 (tr)
ES (1) ES2729490T3 (tr)
TR (1) TR201908151T4 (tr)
WO (1) WO2016055482A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180132629A (ko) * 2016-02-25 2018-12-12 아셰뉴론 에스아 글리코시다제 저해제
US10370355B2 (en) 2016-04-13 2019-08-06 Ucb Biopharma Sprl Tetrahydroisoquinoline derivatives
CN109485597A (zh) * 2017-09-12 2019-03-19 浙江九洲药物科技有限公司 4-卤代异吲哚啉盐酸盐的制备方法
TWI725408B (zh) 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
WO2021216973A1 (en) * 2020-04-24 2021-10-28 The Regents Of The University Of California Nurr1 receptor modulators and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX347928B (es) * 2011-01-10 2017-05-19 Celgene Corp Derivados de fenetilsulfona isoindolina y su uso.
BR112014009717B1 (pt) * 2011-11-29 2022-06-14 Genentech, Inc Derivados de 2-(fenil ou pirid-3-il)aminopirimidina, seus usos, e composição farmacêutica

Also Published As

Publication number Publication date
EP3204374A1 (en) 2017-08-16
EP3204374B1 (en) 2019-04-03
WO2016055482A1 (en) 2016-04-14
US20170313677A1 (en) 2017-11-02
US9975873B2 (en) 2018-05-22
ES2729490T3 (es) 2019-11-04

Similar Documents

Publication Publication Date Title
EA201790785A1 (ru) Производные тетрагидроизохинолина
MX381313B (es) Derivados de benzimidazol como moduladores de ror-gamma
EA201590930A1 (ru) Лекарственные формы руксолитиниба с замедленным высвобождением
PH12014500468A1 (en) Heterocyclic compounds and uses thereof
MX375639B (es) Derivados de heterociclilos sustituidos como inhibidores de cdk
MX385332B (es) Moduladores de ror-gamma.
BR112017011972A2 (pt) derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais
PH12016500582B1 (en) Heterocyclic compounds and uses thereof
MX382033B (es) Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
MX2014004766A (es) Inhibidores de arginasa y sus aplicaciones terapeuticas.
MX2015017964A (es) Inhibidores de bromodominio.
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201591363A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
MX376329B (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX373373B (es) Inhibidores de desmetilasa-1 específica de lisina.
PE20151788A1 (es) Inhibidores de bromodominios tetraciclicos
PL410665A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
EA201692300A1 (ru) Производные карбоксамида
TR201908151T4 (tr) İzoindolin türevleri.